Durata Therapeutics (DRTX) in Focus: Stock Up 5.64% - Tale of the Tape


Durata Therapeutics, Inc. (NASDAQ: DRTX) was a big mover last session, as the company saw its shares jump nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $13.47 to $16.67 in the past one-month time frame, showed a pick-up yesterday at $14.23.

In the last 30 days, the company witnessed 1 upward estimate revision while 2 estimates were revised downward. Also, the Zacks Consensus Estimate of a loss has widened, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this high can last.

Durata Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) and Aastrom Biosciences, Inc. (NASDAQ: ASTM) all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




 
ALEXION PHARMA (NASDAQ: ALXN): Free Stock Analysis Report
 
ANI PHARMACEUT (NASDAQ: ANIP): Free Stock Analysis Report
 
AASTROM BIOSCI (NASDAQ: ASTM): Get Free Report
 
DURATA THERAPT (NASDAQ: DRTX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!